This article is to compare the mechanism of immunoglobulin therapy in PID and autoimmune disease especially Kawasaki disease and to investigate the effectiveness of immunoglobulin therapy. Intriguingly, the dose of the IVIG is different between treatment of PID and autoimmune disease. Patient with autoimmune disease need a much higher dose to manage their symptoms than patient who are using IVIG to manage PID symptoms.